RET inhibition in novel patient-derived models of RET-fusion positive lung adenocarcinoma reveals a role for MYC upregulation von Hayashi, Takuo, Odintsov, Igor, Smith, Roger S, Ishizawa, Kota, Liu, Allan J W, Delasos, Lukas, Kurzatkowski, Christopher, Tai, Huichun, Gladstone, Eric, Vojnic, Morana, Kohsaka, Shinji, Suzawa, Ken, Liu, Zebing, Kunte, Siddharth, Mattar, Marissa S, Khodos, Inna, Davare, Monika A, Drilon, Alexander, Cheng, Emily, Stanchina, Elisa de, Ladanyi, Marc, Somwar, Romel

Volltext

Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements von Schram, Alison M, Odintsov, Igor, Espinosa-Cotton, Madelyn, Khodos, Inna, Sisso, Whitney J, Mattar, Marissa S, Lui, Allan J W, Vojnic, Morana, Shameem, Sara H, Chauhan, Thrusha, Torrisi, Jean, Ford, Jim, O'Connor, Marie N, Geuijen, Cecile A W, Schackmann, Ron C J, Lammerts van Bueren, Jeroen J, Wasserman, Ernesto, de Stanchina, Elisa, O'Reilly, Eileen M, Ladanyi, Marc, Drilon, Alexander, Somwar, Romel

Volltext

The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions von Odintsov, Igor, Lui, Allan J W, Sisso, Whitney J, Gladstone, Eric, Liu, Zebing, Delasos, Lukas, Kurth, Renate I, Sisso, Exequiel M, Vojnic, Morana, Khodos, Inna, Mattar, Marissa S, de Stanchina, Elisa, Leland, Shawn M, Ladanyi, Marc, Somwar, Romel

Volltext

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions von Sato, Hiroki, Schoenfeld, Adam J, Siau, Evan, Lu, Yue Christine, Tai, Huichun, Suzawa, Ken, Kubota, Daisuke, Lui, Allan J W, Qeriqi, Besnik, Mattar, Marissa, Offin, Michael, Sakaguchi, Masakiyo, Toyooka, Shinichi, Drilon, Alexander, Rosen, Neal X, Kris, Mark G, Solit, David, De Stanchina, Elisa, Davare, Monika A, Riely, Gregory J, Ladanyi, Marc, Somwar, Romel

Volltext

Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers von Odintsov, Igor, Mattar, Marissa S., Lui, Allan J.W., Offin, Michael, Kurzatkowski, Christopher, Delasos, Lukas, Khodos, Inna, Asher, Marina, Daly, Robert M., Rekhtman, Natasha, de Stanchina, Elisa, Ganji, Gopinath, Ladanyi, Marc, Somwar, Romel

Volltext

CIC-Mediated Modulation of MAPK Signaling Opposes Receptor Tyrosine Kinase Inhibitor Response in Kinase-Addicted Sarcoma von Odintsov, Igor, Ortiz, Michael V, Khodos, Inna, Mattar, Marissa S, Lui, Allan J W, Kohsaka, Shinji, de Stanchina, Elisa, Bender, Julia L Glade, Ladanyi, Marc, Somwar, Romel

Volltext

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations von Miyazaki, Isao, Odintsov, Igor, Ishida, Keiji, Lui, Allan J W, Kato, Masanori, Suzuki, Tatsuya, Zhang, Tom, Wakayama, Kentaro, Kurth, Renate I, Cheng, Ryan, Fujita, Hidenori, Delasos, Lukas, Vojnic, Morana, Khodos, Inna, Yamada, Yukari, Ishizawa, Kota, Mattar, Marissa S, Funabashi, Kaoru, Chang, Qing, Ohkubo, Shuichi, Yano, Wakako, Terada, Ryuichiro, Giuliano, Claudio, Lu, Yue Christine, Bonifacio, Annalisa, Kunte, Siddharth, Davare, Monika A, Cheng, Emily H, de Stanchina, Elisa, Lovati, Emanuela, Iwasawa, Yoshikazu, Ladanyi, Marc, Somwar, Romel

Volltext

Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations von Miyazaki, Isao, Odintsov, Igor, Ishida, Keiji, Lui, Allan J. W., Kato, Masanori, Suzuki, Tatsuya, Zhang, Tom, Wakayama, Kentaro, Kurth, Renate I., Cheng, Ryan, Fujita, Hidenori, Delasos, Lukas, Vojnic, Morana, Khodos, Inna, Yamada, Yukari, Ishizawa, Kota, Mattar, Marissa S., Funabashi, Kaoru, Chang, Qing, Ohkubo, Shuichi, Yano, Wakako, Terada, Ryuichiro, Giuliano, Claudio, Lu, Yue Christine, Bonifacio, Annalisa, Kunte, Siddharth, Davare, Monika A., Cheng, Emily H., de Stanchina, Elisa, Lovati, Emanuela, Iwasawa, Yoshikazu, Ladanyi, Marc, Somwar, Romel

Volltext

MODL-01. TRACTABLE PATIENT-DERIVED MODELS FOR PRECLINICAL THERAPEUTIC STUDIES OF CNS METASTASES von Vojnic, Morana, Odintsov, Igor, Offin, Michael D, Lui, Allan J W, Khodos, Inna, Chang, Qing, Mattar, Marissa S, De Stanchina, Elisa, Ladanyi, Marc, Somwar, Romel

Volltext

The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with oncogenic NRG1 fusions von Odintsov, Igor, Lui, Allan J W, Sisso, Whitney J, Gladstone, Eric, Liu, Zebing, Delasos, Lukas, Kurth, Renate I, Sisso, Exequiel M, Vojnic, Morana, Khodos, Inna, Mattar, Marissa S, de Stanchina, Elisa, Leland, Shawn M, Ladanyi, Marc, Somwar, Romel

Volltext

A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation von Ganguly, Payel, Madonsela, Landiso, Chao, Jesse T, Loewen, Christopher J R, O'Connor, Timothy P, Verheyen, Esther M, Allan, Douglas W

Volltext

A 2-ns cycle, 3.8-ns access 512-kb CMOS ECL SRAM with a fully pipelined architecture von Chappell, T.I., Chappell, B.A., Schuster, S.E., Allan, J.W., Klepner, S.P., Joshi, R.V., Franch, R.L.

Volltext

Silver Door Facings of the Safavid Period von Allan, J. W.

Volltext

Ḥājjī 'Abbās von Allan, J. W.

Volltext

The observer's book on meteorology von Alexander, William, aviation instructor

Volltext bestellen

RET inhibition in novel patient-derived models of RET-fusion positive lung adenocarcinoma reveals a role for MYC upregulation von Hayashi, Takuo, Odintsov, Igor, Smith, Roger S, Ishizawa, Kota, Liu, Allan J W, Delasos, Lukas, Kurzatkowski, Christopher, Tai, Huichun, Gladstone, Eric, Vojnic, Morana, Kohsaka, Shinji, Suzawa, Ken, Liu, Zebing, Kunte, Siddharth, Mattar, Marissa S, Khodos, Inna, Davare, Monika A, Drilon, Alexander, Cheng, Emily, Stanchina, Elisa de, Ladanyi, Marc, Somwar, Romel

Volltext

Abstract B157: Preclinical evaluation of the blood-brain barrier permeability and intracranial efficacy of the next-generation RET inhibitor Vepafestinib von Odintsov, Igor, Wakayama, Kentaro, Zhang, Tom, Iguchi, Satoru, Kato, Masanori, Lui, Allan JW, Khodos, Inna, Vojnic, Morana, Giuliano, Claudio, Bonifacio, Annalisa, Davare, Monika A, de Stanchina, Elisa, Lovati, Emanuela, Ladanyi, Marc, Miyazaki, Isao, Somwar, Romel

Volltext

Carcass composition of cull sows von Aziz, N.N, Rae, W.A, Allan, J.W, Ball, R.O

Volltext

Relationships between carcass weights, backfat and loin muscle depth in cull sows von AZIZ, N. N, RAE, W. A, ALLAN, J. W, BALL, R. O

Volltext

New Additions to the New Edition von Allan, J. W.

Volltext